A Phase 1 Study, in Cystic Fibrosis Patients, of the Safety, Toxicity, and Biological Efficacy of a Single Administration of a Replication Deficient, Recombinant Adenovirus Carrying the cDNA of the Normal Cystic Fibrosis Transmembrane Conductance Regulator Gene in the Lung. National Institutes of Health, Bethesda, Maryland
Authors:
- Ari JaffeAJAri Jaffe
- Steve BrodySBSteve Brody
- Andrea MastrangeliAMAndrea Mastrangeli
- Noel G. McElvaneyNMNoel G. McElvaney
- Melissa RosenfeldMRMelissa Rosenfeld
- Chin-Shyan ChuCCChin-Shyan Chu
- Claire DanelCDClaire Danel
- John HayJHJohn Hay
- Tony EissaTETony Eissa
- 1 May 1995
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 6 (5) , 643-666